Pune, India -- (SBWIRE) -- 04/11/2019 -- Our latest research report entitled Marine-derived Drugs Market (by type (phenol, steroid, ether, peptide, and other), source (algae, invertebrates, microorganisms), mode of delivery (anti-microbial, anti-tumor, anti-cardiovascular, anti-viral, anti-inflammatory, and others)) Industry Analysis, Trends, Size, Share and Forecasts to 2025 provides complete and deep insights into the market dynamics and growth of Marine-derived Drugs. Latest information on market risks, industry chain structure Marine-derived Drugs cost structure and opportunities are offered in this report. The past, present and forecast market information will lead to investment feasibility by studying the essential Marine-derived Drugs growth factors.

For More Details Get FREE Sample Pages of this Research Report@ https://www.infiniumglobalresearch.com/reports/sample-request/5363

The forecast Marine-derived Drugs Market information is based on the present market situation, growth opportunities, development factors, and opinion of the industry experts. An in-depth analysis of the company profiles, Marine-derived Drugs on a global and regional level and applications is conducted. The analysis of downstream buyers, sales channel, raw materials, and industry verticals is offered in this report. The global marine-derived drugs market is projected to grow at a CAGR of 11.2% over the forecast period of 2019-2025.

Marine-Derived Drug Market: Industry Insight

The use of the natural product as templates or starting materials in the drug formation is gaining popularity from the past few decades. The marine organisms become the most attractive general for the bioactive molecules used in the pharmaceutical industry. The adoption of marine-derived bioactive components as the traditional source in modern pharmaceutical is rising rapidly. The global marine-derived drug Market was sized near USD 10,486.8 million in 2018 and it is expected to reach USD 21,955.6 million by 2025. The global marine-derived drug market is projected to grow with a CAGR of 11.20% during 2019-2025.

Marine-Derived Drug Market: Driver and Restrain

The growing adoption of marine-derived drugs in the treatment of tumors causing diseases is driving the growth of marine-derived drugs market worldwide. They are also vastly being used in the treatment of infectious diseases, tuberculosis, malaria, osteoporosis, and HIV. In addition, the introduction of new screening technology and growing exploration of marine environment activities are majorly contributing to the growth of marine-derived drugs market. On the other hand, the high cost of processing and manufacturing of marine-derived drugs market are hampering the growth of this market. Moreover, ongoing research and developments in the Marine pharmacognosy are expected to create the huge demand of marine bioactive components in the drug manufacturing over the forecast period. Additionally, the growing awareness about the marine-derived drugs is projected to serve various opportunities in the marine-derived drug market in the near future.

Request a Discount on Standard Prices of this Premium Report @ https://www.infiniumglobalresearch.com/reports/request-discount/5363

Marine-Derived Drug Market: Segmentation

The global market of marine-derived drug market is segmented into type, Source, and mode of delivery. In terms of source, the market is further divided into Phenol, Steroid, Ether, Peptide, and Others. Among these types, the peptide segment accounted to be the largest market share in the marine-derived drug market. Peptides are short chains of amino acids monomers. Peptides are used as antioxidative, antimicrobial, antihypertensive, cytomodulatory and immunomodulatory in the medical sector. They have a large amount of nutraceutical and medicinal value owing to their broad spectra of bioactivities. Thus, this drives the growth of Peptide in the marine-derived drug market.

Based on the source, the marine-derived drug market id bifurcated into Algae, Invertebrates, and Microorganisms. Invertebrates hold the maximum market share in the marine-derived drugs to market. It is anticipated to be the dominating segmented during the forecast period. Marine invertebrates are one of the major groups of marine organisms. Marine invertebrates such as mollusks and crustaceans have been linked with various medicinal benefits to improve human health. The growing use of invertebrate organisms in the pharmaceutical is contributing to the growth of marine-derived drug market.

On the basis of delivery of mode, the market is further categorized into, Anti-microbial, Anti-tumor, Anti-cardiovascular, Anti-viral, Anti-inflammatory, and others. The several marine Microorganisms have anti-cancer properties. Thus these anti-tumor drugs are vastly used in the cancer treatment. Additionally, the growing prevalence of cancer is the key factor that drives the growth of anti-tumor drugs market.

Marine-Derived Drug Market: Regional Insight

Geographically, North America is the dominating region in the marine-derived drug market. The growing research and developments are the Marnie pharmacognosy is the primary factor that drives the growth of marine-derived drug market. The factors such as the growing prevalence of cancer and infection diseases and the rapidly growing adoption of marine-derived drugs are also contributing to the growth of this market in the North America region. Additionally, the Asia Pacific is growing with the highest CAGR of 13.37% over the forecast period.

Read Detailed Index of full Research Study at https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-marine-derived-drugs-market

Marine-Derived Drug Market: Competitive Landscape

The key players in the marine-derived drug market include Pfizer, Abbott Laboratories, GlaxoSmithKline PLC, Perrigo, Pharma Mar S.A, Eisai Co., Ltd., Aker BioMarine AS, Sea Run Holdings, Inc., Aphios Corporation, Pharma Marine USA, LLC, and others. These players have been focusing on expanding they're geographical as well as an industrial reach by entering into acquisitions and the collaborations. For instance, in September 2017, Eisai entered into a collaboration agreement with Ono Pharmaceutical Co., Ltd. (Osaka) to jointly develop the combination therapy of Lenvima and anti-PD-1 antibody nivolumab of Ono Pharmaceutical Co., Ltd. for the treatment of hepatocellular carcinoma.

Reasons to Buy this Report:

- Comprehensive analysis of global as well as regional markets of the Marine-derived Drugs.

- Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2025.

- Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.

- Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.